These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 26367865)
41. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [TBL] [Abstract][Full Text] [Related]
42. Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial. Kristoffersen ES; Straand J; Vetvik KG; Benth JŠ; Russell MB; Lundqvist C J Neurol Neurosurg Psychiatry; 2015 May; 86(5):505-12. PubMed ID: 25112307 [TBL] [Abstract][Full Text] [Related]
43. Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain. Rauck RL; Potts J; Xiang Q; Tzanis E; Finn A Postgrad Med; 2016 Jan; 128(1):1-11. PubMed ID: 26634956 [TBL] [Abstract][Full Text] [Related]
45. Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study. Worley MJ; Swanson A-N; Heinzerling KG; Roche DJ; Shoptaw S Drug Alcohol Depend; 2016 May; 162():245-50. PubMed ID: 26993372 [TBL] [Abstract][Full Text] [Related]
46. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study. Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816 [TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study. Hale ME; Ahdieh H; Ma T; Rauck R; J Pain; 2007 Feb; 8(2):175-84. PubMed ID: 17145204 [TBL] [Abstract][Full Text] [Related]
48. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476 [TBL] [Abstract][Full Text] [Related]
49. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. Karst M; Salim K; Burstein S; Conrad I; Hoy L; Schneider U JAMA; 2003 Oct; 290(13):1757-62. PubMed ID: 14519710 [TBL] [Abstract][Full Text] [Related]
50. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Southworth S; Peters J; Rock A; Pavliv L Clin Ther; 2009 Sep; 31(9):1922-35. PubMed ID: 19843482 [TBL] [Abstract][Full Text] [Related]
51. Prevention and management of medication overuse headache. Russell MB; Lundqvist C Curr Opin Neurol; 2012 Jun; 25(3):290-5. PubMed ID: 22547100 [TBL] [Abstract][Full Text] [Related]
52. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197 [TBL] [Abstract][Full Text] [Related]
53. Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. Sandrini G; Perrotta A; Tassorelli C; Torelli P; Brighina F; Sances G; Nappi G J Headache Pain; 2011 Aug; 12(4):427-33. PubMed ID: 21499747 [TBL] [Abstract][Full Text] [Related]
54. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472 [TBL] [Abstract][Full Text] [Related]
55. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. Silberstein SD; Blumenfeld AM; Cady RK; Turner IM; Lipton RB; Diener HC; Aurora SK; Sirimanne M; DeGryse RE; Turkel CC; Dodick DW J Neurol Sci; 2013 Aug; 331(1-2):48-56. PubMed ID: 23790235 [TBL] [Abstract][Full Text] [Related]
56. Decision-making deficit in chronic migraine patients with medication overuse. Biagianti B; Grazzi L; Gambini O; Usai S; Muffatti R; Scarone S; Bussone G Neurol Sci; 2012 May; 33 Suppl 1():S151-5. PubMed ID: 22644192 [TBL] [Abstract][Full Text] [Related]